Answers are grounded in this paper and cite their sources.
Persistent bacterial lung infections in children lead to significant morbidity and mortality due to antibiotic resistance. In this paper, we describe how phage therapy has shown remarkable efficacy in preclinical and clinical studies, demonstrating significant therapeutic benefits through various administration routes. Ongoing trials are evaluating its safety and effectiveness against different pathogens. Advancing phage therapy through systematic studies and international collaboration could provide a viable alternative to traditional antibiotics for persistent infections.
No takes yet. Share an insight, caveat, or question.
Shein et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: